Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis

Molecular Genetics and Metabolism

Volumn 94, Issue 2, 2008, Pages 212-221

  Martin, Douglas R ^a   Rigat, Brigitte A ^b   Foureman, Polly ^a   Varadarajan, G S ^a   Hwang, Misako ^a   Krum, Barbara K ^a   Smith, Bruce F ^a   Callahan, John W ^b   Mahuran, Don J ^b   Baker, Henry J ^a  

^a AUBURN UNIVERSITY   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Animal model; Feline; GM1 gangliosidosis; Galactosidase; Lysosomal storage disease

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; MESSENGER RNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; GENE MUTATION; GLYCOSYLATION; GM1 GANGLIOSIDOSIS; IMMUNOFLUORESCENCE; LYSOSOME; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID SUBSTITUTION; ANIMALS; BETA-GALACTOSIDASE; CAT DISEASES; CATS; CELL LINE; CELLS, CULTURED; CLONING, MOLECULAR; FIBROBLASTS; GANGLIOSIDOSIS, GM1; HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; OPEN READING FRAMES; PROTEIN DISULFIDE-ISOMERASE; PROTEIN TRANSPORT;

ANIMALIA; FELIDAE;

EID: 43249114793     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2008.02.004     Document Type: Article

References (60)

1. Callahan J.W. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like protein. Biochim. Biophys. Acta 1455 (1999) 85-103
2. Gilbert D.A., O'Brien J.S., and O'Brien S.J. Chromosomal mapping of lysosomal enzyme structural genes in the domestic cat. Genomics 2 (1988) 329-336
3. Georgiou T., Stylianidou G., Anastasiadou V., Caciotti A., Campos Y., Zammarchi E., Morrone A., D'Azzo A., and Drousiotou A. The Arg482His mutation in the β-galactosidase gene is responsible for a high frequency of GM1 gangliosidosis carriers in a Cypriot village. Genet. Test. 9 (2005) 126-132
4. Ishii N., Oohira T., Oshima A., Sakuraba H., Endo F., Matsuda I., Sukegawa K., Orii T., and Suzuki Y. Clinical and molecular analysis of a Japanese boy with Morquio B disease. Clin. Genet. 48 (1995) 103-108
5. Oshima A., Yoshida K., Shimmoto M., Fukuhara Y., Sakuraba H., and Suzuki Y. Human β-galactosidase gene mutations in morquio B disease. Am. J. Hum. Genet. 49 (1991) 1091-1093
6. Suzuki Y., and Oshima A. A β-galactosidase gene mutation identified in both Morquio B disease and infantile GM1 gangliosidosis. Hum. Genet. 91 (1993) 407
7. Caciotti A., Donati M.A., Boneh A., D'Azzo A., Federico A., Parini R., Antuzzi D., Bardelli T., Nosi D., Kimonis V., Zammarchi E., and Morrone A. Role of β-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis. Hum. Mutat. 25 (2005) 285-292
8. Mosna G., Fattore S., Tubiello G., Brocca S., Trubia M., Gianazza E., Gatti R., Danesino C., Minelli A., and Piantanida M. A homozygous missense arginine to histidine substitution at position 482 of the β-galactosidase in an Italian infantile GM1-gangliosidosis patient. Hum. Genet. 90 (1992) 247-250
9. Baker H.J., Lindsey J.R., McKhann G.M., and Farrell D.F. Neuronal GM1 gangliosidosis in a Siamese cat with β-galactosidase deficiency. Science 174 (1971) 838-839
10. Baker H.J., Reynolds G.D., Walkley S.U., Cox N.R., and Baker G.H. The gangliosidoses: comparative features and research applications. Vet. Pathol. 16 (1979) 635-649
11. Baker H.J., and Jope R.S. Increased metabolism of acetylcholine in brain of cats with Gm1 gangliosidosis. Brain Res. 343 (1985) 363-365
12. Jope R.S., Baker H.J., and Connor D.J. Increased acetylcholine synthesis and release in brains of cats with GM1 gangliosidosis. J. Neurochem. 46 (1986) 1567-1572
13. 2+ flux in synaptosomes from cats with GM1 gangliosidosis. Brain Res. 424 (1987) 169-176
14. Purpura D.P., Pappas G.D., and Baker H.J. Fine structure of meganeurites and secondary growth processes in feline GM1-gangliosidosis. Brain Res. 143 (1978) 1-12
15. Purpura D.P., and Baker H.J. Meganeurites and other aberrant processes of neurons in feline GM1-gangliosidosis: a Golgi study. Brain Res. 143 (1978) 13-26
16. Purpura K.P., and Baker H.J. Neurite induction in mature cortical neurones in feline GM1-ganglioside storage disease. Nature 266 (1977) 553-554
17. Shanker G., and Baker H.J. Phorbol ester receptors in cerebral cortex of cats with GM1 gangliosidosis. Neurochem. Res. 16 (1991) 11-16
18. Singer H.S., Coyle J.T., Weaver D.L., Kawamura N., and Baker H.J. Neurotransmitter chemistry in feline GM1 gangliosidosis: a model for human ganglioside storage disease. Ann. Neurol. 12 (1982) 37-41
19. Walkley S.U., Baker H.J., and Rattazzi M.C. Initiation and growth of ectopic neurites and meganeurites during postnatal cortical development in ganglioside storage disease. Brain Res. Dev. Brain Res. 51 (1990) 167-178
20. Wood P.A., McBride M.R., Baker H.J., and Christian S.T. Fluorescence polarization analysis, lipid composition, Na+, K+-ATPase kinetics of synaptosomal membranes in feline GM1 and GM2 gangliosidosis. J. Neurochem. 44 (1985) 947-956
21. Cox N.R., Morrison N.E., Sartin J.L., Buonomo F.C., Steele B., and Baker H.J. Alterations in the growth hormone/insulin-like growth factor I pathways in feline GM1 gangliosidosis. Endocrinology 140 (1999) 5698-5704
22. Cox N.R., Ewald S.J., Morrison N.E., Gentry A.S., Schuler M., and Baker H.J. Thymic alterations in feline GM1 gangliosidosis. Vet. Immunol. Immunopathol. 63 (1998) 335-353
23. Steiss J.E., Baker H.J., Braund K.G., Cox N.R., and Wright J.C. Profile of electrodiagnostic abnormalities in cats with GM1 gangliosidosis. Am. J. Vet. Res. 58 (1997) 706-709
24. Zhou J., Shao H., Cox N.R., Baker H.J., and Ewald S.J. Gangliosides enhance apoptosis of thymocytes. Cell. Immunol. 183 (1998) 90-98
25. Nanba E., and Suzuki K. Molecular cloning of mouse acid β-galactosidase cDNA: sequence, expression of catalytic activity and comparison with the human enzyme. Biochem. Biophys. Res. Commun. 173 (1990) 141-148
26. Oshima A., Tsuji A., Nagao Y., Sakuraba H., and Suzuki Y. Cloning, sequencing, and expression of cDNA for human β-galactosidase. Biochem. Biophys. Res. Commun. 157 (1988) 238-244
27. Morreau H., Bonten E., Zhou X.Y., and D'Azzo A. Organization of the gene encoding human lysosomal β-galactosidase. DNA Cell Biol. 10 (1991) 495-504
28. Nanba E., and Suzuki K. Organization of the mouse acid β-galactosidase gene. Biochem. Biophys. Res. Commun. 178 (1991) 158-164
29. D.R. Martin, Gene Therapy of the Gangliosidoses, Auburn University, 1999 (dissertation).
30. Zhang S., Bagshaw R., Hilson W., Oho Y., Hinek A., Clarke J.T., and Callahan J.W. Characterization of β-galactosidase mutations Asp332→Asn and Arg148→Ser, and a polymorphism, Ser532→Gly, in a case of GM1 gangliosidosis. Biochem. J. 348 (2000) 621-632
31. Privitera S., Prody C.A., Callahan J.W., and Hinek A. The 67-kDa enzymatically inactive alternatively spliced variant of β-galactosidase is identical to the elastin/laminin-binding protein. J. Biol. Chem. 273 (1998) 6319-6326
32. McCluskie M.J., Weeratna R.D., Payette P.J., and Davis H.L. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol. Med. Microbiol. 32 (2002) 179-185
33. Martin D.R., Krum B.K., Varadarajan G.S., Hathcock T.L., Smith B.F., and Baker H.J. An inversion of 25 base pairs causes feline GM2 gangliosidosis variant 0. Exp. Neurol. 187 (2004) 30-37
34. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
35. Xie B., Wang W., and Mahuran D.J. A Cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. Am. J. Hum. Genet. 50 (1992) 1046-1052
36. Birmingham C.L., and Brumell J.H. Autophagy recognizes intracellular Salmonella enterica serovar Typhimurium in damaged vacuoles. Autophagy 2 (2006) 156-158
37. Okamura-Oho Y., Zhang S., Hilson W., Hinek A., and Callahan J.W. Early proteolytic cleavage with loss of a C-terminal fragment underlies altered processing of the β-galactosidase precursor in galactosialidosis. Biochem. J. 313 (1996) 787-794
38. Zar J.H. Biostatistical Analysis (1984), Prentice-Hall, Englewood Cliffs, NJ
39. Yamamoto Y., Hake C.A., Martin B.M., Kretz K.A., Ahern-Rindell A.J., Naylor S.L., Mudd M., and O'Brien J.S. Isolation, characterization, and mapping of a human acid β-galactosidase cDNA. DNA Cell Biol. 9 (1990) 119-127
40. Yamato O., Ochiai K., Masuoka Y., Hayashida E., Tajima M., Omae S., Iijima M., Umemura T., and Maede Y. GM1 gangliosidosis in Shiba dogs. Vet. Res. 146 (2000) 493-496
41. Yamato O., Endoh D., Kobayashi A., Masuoka Y., Yonemura M., Hatakeyama A., Satoh H., Tajima M., Yamasaki M., and Maede Y. A novel mutation in the gene for canine acid β-galactosidase that causes GM1-gangliosidosis in Shiba dogs. J. Inherit. Metab. Dis. 25 (2002) 525-526
42. Prieur D.J., Ahern-Rindell A.J., and Murnane R.D. Ovine GM-1 gangliosidosis. Am. J. Pathol. 139 (1991) 1511-1513
43. Skelly B.J., Jeffrey M., Franklin R.J., and Winchester B.G. A new form of ovine GM1-gangliosidosis. Acta Neuropathol. 89 (1995) 374-379
44. Hahn C.N., del Pilar M., Schroder M., Vanier M.T., Hara Y., Suzuki K., and D'Azzo A. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid β-galactosidase. Hum. Mol. Genet. 6 (1997) 205-211
45. Matsuda J., Suzuki O., Oshima A., Ogura A., Naiki M., and Suzuki Y. Neurological manifestations of knockout mice with β-galactosidase deficiency. Brain Dev. 19 (1997) 19-20
46. Tessitore A., del P.M., sano R., Ma Y., Mann L., Ingrassia A., Laywell E.D., Steindler D.A., Hendershot L.M., and D'Azzo A. GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell 15 (2004) 753-766
47. Butler A., Gordon R.E., Gatt S., and Schuchman E.H. Sperm abnormalities in heterozygous acid sphingomyelinase knockout mice reveal a novel approach for the prevention of genetic diseases. Am. J. Pathol. 170 (2007) 2077-2088
48. Fan J., Akabane H., Graham S.N., Richardson L.L., and Zhu G.Z. Sperm defects in mice lacking a functional Niemann-Pick C1 protein. Mol. Reprod. Dev. 73 (2006) 1284-1291
49. Luddi A., Strazza M., Carbone M., Moretti E., and Costantino-Ceccarini E. Galactosylceramidase deficiency causes sperm abnormalities in the mouse model of globoid cell leukodystrophy. Exp. Cell Res. 304 (2005) 59-68
50. Zhang S., McCarter J.D., Okamura-Oho Y., Yaghi F., Hinek A., Withers S.G., and Callahan J.W. Kinetic mechanism and characterization of human β-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells. Biochem. J. 304 (1994) 281-288
51. Zhao L., and Ackerman S.L. Endoplasmic reticulum stress in health and disease. Curr. Opin. Cell Biol. 18 (2006) 444-452
52. Xu C., Bailly-Maitre B., and Reed J.C. Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115 (2005) 2656-2664
53. Zhang K., and Kaufman R.J. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66 (2006) S102-S109
54. Ron I., and Horowitz M. ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity. Hum. Mol. Genet. 14 (2005) 2387-2398
55. Fan J.Q., Ishii S., Asano N., and Suzuki Y. Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 5 (1999) 112-115
56. Ishii S., Chang H.H., Kawasaki K., Yasuda K., Wu H.L., Garman S.C., and Fan J.Q. Mutant α-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin. Biochem. J. 406 (2007) 285-295
57. Kim S.J., Zhang Z., Hitomi E., Lee Y.C., and Mukherjee A.B. Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL. Hum. Mol. Genet. 15 (2006) 1826-1834
58. Kim S.J., Zhang Z., Lee Y.C., and Mukherjee A.B. Palmitoyl-protein thioesterase-1 deficiency leads to the activation of caspase-9 and contributes to rapid neurodegeneration in INCL. Hum. Mol. Genet. 15 (2006) 1580-1586
59. Zhang Z., Lee Y.C., Kim S.J., Choi M.S., Tsai P.C., Xu Y., Xiao Y.J., Zhang P., Heffer A., and Mukherjee A.B. Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL. Hum. Mol. Genet. 15 (2006) 337-346
60. Martin D.R., Cox N.R., Morrison N.E., Kennamer D.M., Peck S.L., Dodson A.N., Gentry A.S., Griffin B., Rolsma M.D., and Baker H.J. Mutation of the GM2 activator protein in a feline model of GM2 gangliosidosis. Acta Neuropathol. 110 (2005) 443-450